软组织肉瘤诊治中国专家共识（2015年版）

Chinese expert consensus on diagnosis and treatment of soft tissue sarcomas （Version 2015）

软组织肉瘤是一类间叶来源的恶性肿瘤，可发生于全身各个部位，各年龄段均可发病。由于发病率低，种类繁多且生物学行为各异，如何规范诊疗一直是临床工作的难点。外科治疗仍然是软组织肉瘤唯一可获得根治和最重要的治疗手段，但在某些肉瘤类型或某些情形下需要进行化疗和放疗，靶向治疗也显示出了良好的前景。目前，对于如何实施规范的多学科综合治疗，如何配合应用各种治疗手段，尚缺乏普遍认可的共识。中国抗癌协会肉瘤专业委员会和中国临床肿瘤学会以循证医学证据为基础，同时吸纳了部分已获认可的专家经验和研究心得，深入探讨了软组织肉瘤的多学科综合治疗，形成了中国专家共识以期为临床诊疗活动发挥指导性作用。

Soft tissue sarcoma is a group of malignancies of mesenchymal origin. It arises from almost every part of human body in all decades. Appropriate dagnosis and treatment of soft tissue sarcoma are always challenging to physicians and pathologists because of its extremely low incidence and variable biological behaviors among subtypes. Surgical resection remains the most important and only method to cure soft tissue sarcomas, while chemoradiation and target therapy are incorporated into multidisciplinary treatment model, but there is no generally accepted consensus on how to do multidisciplinary treatment properly and maximize the therapeutic effects. The aim of this article is to improve the understanding of multidisciplinary treatment of soft tissue sarcomas and to provide a guidance nationwide based on evidence-based medicine and expert′s experience on related topics.